LENZ Therapeutics, Inc.(LENZ) - 2022 Q2 - Quarterly Report

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 (Exact Name of Registrant as Specified in its Charter) Delaware 84-4867570 ( State or other jurisdiction of incorporation or organization) 201 Haskins Way, Suite 210 South San Francisco, CA 94080 (I.R.S. Employer Identification No.) (Address of principal executive offices) (Zip Code) For the quarterly period ended June 30, 2022 O ...